Alain FournetAngel BarriosVictoria MuñozReynald HocquemillerAndré Cavé2026-03-222026-03-22199310.1002/ptr.2650070404https://doi.org/10.1002/ptr.2650070404https://andeanlibrary.org/handle/123456789/48166Citaciones: 33Abstract Four bisbenzylisoquinoline alkaloids, antioquine, berbamine, gyrocarpine and isotetrandrine were tested in BALB/c mice infected with Leishmania amazonensis (IFLA/BR/67/PH8 or MHOM/GF/84/CAY‐H‐142) or L. venezuelensis (VE/74/PM‐H3). The treatments were initiated 1 day after the parasitic infection, with alkaloid at 100 mg/kg/day for 14 days and the reference compound, meglumine antimonate (Glucantime R ) at 200 mg/kg/day. Antioquine, berbamine and gyrocarpine were less potent than Glucantime against L. amazonensis (PH8). Only isotetrandrine exhibited activity approximately equal to or greater than Glucantime in BALB/c mice infected with L. amazonensis (PH8 or H‐142) and showed significant activity against L. venezuelensis . Experiments with a single local treatment on the footpad, 2 weeks after parasitic infection with L. amazonensis (PH8), showed that isotetrandrine at 200 mg/kg was less active than Glucantime at 400 mg/kg.enAlkaloidPharmacologyBerberidaceaeBALB/cMenispermaceaeLeishmaniaPharmacognosyTraditional medicineChemistryMedicinearticle